|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 401 Ninth Street NW, Suite 900 |
Address2 |
|
| City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 27057-12
|
||||||||
|
6. House ID# 302500000
|
||||||||
| TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Beth Feldpush |
Date | 10/21/2019 3:26:23 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues pertaining to Medicaid reform, block grant proposals, per capita caps
Medicare and Medicaid Graduate Medical Education
Medicare bad debt payments
Medicaid waivers
Medicaid Expansion Issues
Medicaid Disproportionate Share Hospital Payments
Medicare Disproportionate Share Hospital Payments
Legislation related to chronic care treatment
Medicaid supplemental payments to hospitals
Medicare site neutral payments for hospitals outpatient departments
Legislation related to healthcare disparities
Medicaid State Flexibility
Medicaid 1115 & 1332 Waivers
Upper Payment Limit payments
State Financing of Medicaid
Medicare Part B Cuts-OPPS proposed rule to 340B covered entities
Hospital Price Transparency
National Quality Forum Funding
Medicaid & CHIP Coverage
Medicaid Funding for Certified Community Behavioral Health Centers
Medicaid Funding for Community-Based long-term care
H.R. 2328 - REACH Act
H.R. 3414 - Opioid Workforce Act of 2019
S.1699 - Prescription Drug Cost Reduction Act
H.R.3 - Lower Drug Costs Now Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Jocelyn |
Wiles |
|
|
|
Carlos |
Jackson |
|
|
|
Margaret |
Peterson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Repeal of the Affordable Care Act
Development of legislation to protect essential hospitals
Issues related to telehealth
Mental Health
Essential Health Benefits created by the Affordable Care Act
Access to hospital emergency services
Issues related to the 340B Drug Pricing Program
340B dug pricing program
CMS OPPS 340B rule moratorium-related legislation
42 CFR Part 2
CREATES Act-H.R. 965
Cassidy Surprise Billing Draft
Protecting Patients from Surprise Medical Bills
Excellence in Metal Health Act (S. 824/H.R. 1767)
Patient Centered Outcomes Research Institute Funding
No Surprises Act
Lower Health Care Costs Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Jocelyn |
Wiles |
|
|
|
Carlos |
Jackson |
|
|
|
Margaret |
Peterson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Bipartisan Budget Act of 2015
H.R. 1892, The Bipartisan Budget Act of 2018 (Medicaid DSH)
H.R. 4378 - Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Jocelyn |
Wiles |
|
|
|
Carlos |
Jackson |
|
|
|
Margaret |
Peterson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |